NICE chief demands transparency over trial data

Sir Andrew Dillon

The National Institute for Health and Care Excellence chief executive has said that the pharmaceutical industry should disclose more data from clinical trials.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters

Already a subscriber? Sign into your account here